Security key
M96088105
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)
CUSIP: M96088105
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Total 13F shares
- 35,097,143
- Total 13F value
- $445,735,362
- Share change
- -3,438,455
- Put/Call ratio
- 426%
- SEC-reported price per share
- $12.70
- Number of holders
- 127
- Value change
- -$58,506,168
- Number of buys
- 71
- Number of sells
- 41
- Shares outstanding
- 48,684,257
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
127
Top holders
10
URGN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
UroGen Pharma Ltd. SEC filings
UroGen Pharma Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M96088105
Recent filing periods:
Ownership snapshot
Top reported holders of URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 7.3%
Showing 1-6 of 15 holder rows.
Quick read
RTW INVESTMENTS, LP leads the comparable SEC ownership view at 7.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RTW INVESTMENTS, LP's linked filing trail.
Comparable ownership
Top 5
RTW INVESTMENTS, LP
7.3%
ADAGE CAPITAL PARTNERS GP, L.L.C.
6.8%
RA CAPITAL MANAGEMENT, L.P.
6.3%
GREAT POINT PARTNERS LLC
6%
Point72 Asset Management, L.P.
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
Company
|
7.3%
|
$59,692,283
3,557,347 shares
|
— | 30 Jun 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
6.8%
|
$55,374,000
3,300,000 shares
|
— | 30 Jun 2024 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
6.3%
|
$51,739,955
3,083,430 shares
|
— | 30 Jun 2024 |
| GREAT POINT PARTNERS LLC |
13F
Company
|
6%
|
$48,767,026
2,906,259 shares
|
— | 30 Jun 2024 |
| Point72 Asset Management, L.P. |
13F
Company
|
5%
|
$41,098,865
2,449,277 shares
|
— | 30 Jun 2024 |
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
Company
|
4.7%
|
$38,644,860
2,303,031 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
127
Shares
35,097,143
Rows available
127
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
114
Q3 2024 holders
127
Holder diff
13
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend